I have reviewed all information that I could find on this company. Different product, different goals, different patient population as target for use... this changes nothing.
As a surgeon working in the abdomen and pelvic if I was to choose between ISRG, Titan or Medrorobotics... Medrorobotics in its current state would not get much consideration.
There will be much competition in this field. The key is to get marketed in the US to abdominal and pelvic surgeons. Titan is looking very good in this regard.
It's not a similar device to SPORT. It has similar technology, and both will be advances in MIS. Initial approvals for both devices will be for entirely different procedures in entirely different therapy areas. Medrorobitics becomes a "player" in minimally invasive surgery and they will have the opportunity to gain a foot-hold in the MIS ENT market - that's it! Other than potential patent infringement issues this should be of little concern for Titan in the near-term. IMO you are making a bigger deal about this than is warranted.
News 
Market Data 
Discover 
AI
